Preoperative planning, surgical instrumentation and bony ingrowth are advancements that surgeon Alan Davis, M.D., says are a must for future total ankles.
Mr. Francesco Siccardi opens up about market opportunities, headwinds and strategies for Medacta while dealing with the COVID-19 outbreak.
In this video, trauma surgeon Peter Althausen, M.D., says COVID-19 will shift procedures to outpatient settings and place scrutiny on implant utilization.
Tiger Buford talks about changes to technology and the roles of product development and sales and marketing post-COVID-19.
Mr. Bihl feels that orthobiologics are in a unique position to address unmet needs that remain prevalent despite advancements in traditional orthopedic products.
First-quarter earnings announcements start in earnest today. We think a clearer picture of the entire orthopedic market could develop in the next month.
Joint replacement surgeon Vinod Dasa, M.D., says there will be a heightened focus on eliminating waste and redundancies, especially in the “last mile” of the supply chain.
While the spine industry has focused on 3D printed cages, enabling technology and minimally invasive surgery, it has forgotten a critical priority: infection prevention, says Aakash Agarwal, Ph.D., Director of Research at Spinal Balance.
Robotic systems would have undoubtedly received major play at the Annual Meeting. We pulled together recent strategic activity to provide greater insight.
In moving to the provider side of orthopedics after spending decades in industry, Doug Leach has learned a valuable lesson: Partner with providers. Not just the surgeon.